FTC disputes “junk” patents blocking generic drugs.
The Impact of “Junk” Patents on Pharmaceutical Industry Competition The recent announcement by the U.S. Federal Trade Commission (FTC) challenging…
Breaking News & Insights for the Masses
The Impact of “Junk” Patents on Pharmaceutical Industry Competition The recent announcement by the U.S. Federal Trade Commission (FTC) challenging…
Pharmaceutical Industry Leaders Prepare for Patent Expirations Two prominent pharmaceutical companies, Merck and Bristol-Myers Squibb, are currently bracing themselves for…